Outset Medical to Participate in Healthcare Conference
News related to:Outset Medical, Inc · 1 min read
SAN JOSE, Calif., Oct. 27, 2026 /CourierPR/ -- Outset Medical, a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, has announced that management will participate in a fireside chat at the 2026 Stifel Healthcare conference. The fireside chat is scheduled to take place on Tuesday, November 10, 2026, at 1:20 p.m. ET.
The company, which is headquartered in San Francisco, California, has a proven track record of success in the healthcare industry. Outset's Tablo® Hemodialysis System, which has been FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses.
Outset's enterprise solution combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control, enabling better operational, clinical, and financial outcomes.
The Tablo system is a game-changer in the dialysis industry, offering a more efficient and cost-effective solution for healthcare facilities. With its FDA clearance and extensive deployment across the United States, Outset is well-positioned to continue its growth and innovation in the healthcare sector.
Outset's participation in the 2026 Stifel Healthcare conference is a testament to the company's commitment to advancing healthcare technology and its leadership in the industry. The fireside chat will provide attendees with a unique opportunity to hear directly from Outset's management team and learn more about the company's innovative solutions.